Related references
Note: Only part of the references are listed.The Role of Paraoxonase 1 (PON1) Gene Polymorphisms in Coronary Artery Disease: A Systematic Review and Meta-Analysis
Sana Ashiq et al.
BIOCHEMICAL GENETICS (2021)
Coronary Artery Disease and Endothelial Dysfunction: Novel Diagnostic and Therapeutic Approaches
Evangelos Oikonomou et al.
CURRENT MEDICINAL CHEMISTRY (2020)
Association of combined genetic variations in SOD3, GPX3, PON1, and GSTT1 with hypertension and severity of coronary artery disease
Nisa Decharatchakul et al.
HEART AND VESSELS (2020)
The combined utility of myeloperoxidase (MPO) and paraoxonase 1 (PON1) as two important HDL-associated enzymes in coronary artery disease: Which has a stronger predictive role?
Atena Variji et al.
ATHEROSCLEROSIS (2019)
Paraoxonase 1 gene (Q192R) polymorphism confers susceptibility to coronary artery disease in type 2 diabetes patients: Evidence from case-control studies
Xiaowei Huo et al.
DRUG DISCOVERIES AND THERAPEUTICS (2019)
Low serum paraoxonase1 activity levels predict coronary artery disease severity
Ting Sun et al.
ONCOTARGET (2017)
Serum paraoxonase-1 activity and risk of incident cardiovascular disease: The PREVEND study and meta-analysis of prospective population studies
Setor K. Kunutsor et al.
ATHEROSCLEROSIS (2016)
Paraoxonases-1,-2 and-3: What are their functions?
Clement E. Furlong et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2016)
PON-1 Activity and Plasma 8-Isoprostane Concentration in Patients with Angiographically Proven Coronary Artery Disease
Agnieszka Kuchta et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
Paraoxonase 1 gene polymorphisms and enzyme activities in coronary artery disease and its relationship to serum lipids and glycemia
Osvaldo Fridman et al.
ARCHIVOS DE CARDIOLOGIA DE MEXICO (2016)
Paraoxonase-1 and Simvastatin Treatment in Patients with Stable Coronary Artery Disease
Rafal Januszek
INTERNATIONAL JOURNAL OF VASCULAR MEDICINE (2016)
Association of elevated apoA-I glycation and reduced HDL-associated paraoxonase1, 3 activity, and their interaction with angiographic severity of coronary artery disease in patients with type 2 diabetes mellitus
Ying Shen et al.
CARDIOVASCULAR DIABETOLOGY (2015)
Effect of statin therapy on paraoxonase-1 status: A systematic review and meta-analysis of 25 clinical trials
Gianna Ferretti et al.
PROGRESS IN LIPID RESEARCH (2015)
Antioxidant Effects of Statins in Patients with Atherosclerotic Cerebrovascular Disease
Gyeong Joon Moon et al.
JOURNAL OF CLINICAL NEUROLOGY (2014)
The Role of 'Paraoxonase-1 Activity' as an Antioxidant in Coronary Artery Diseases
Maharudra Shekhanawar et al.
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH (2013)
Four genetic polymorphisms of paraoxonase gene and risk of coronary heart disease: A meta-analysis based on 88 case-control studies
Mingsong Wang et al.
ATHEROSCLEROSIS (2011)
The relationship between paraoxonase1-192 polymorphism and activity with coronary artery disease
Randa H. Mohamed et al.
CLINICAL BIOCHEMISTRY (2010)
High Prevalence of Low Serum Paraoxonase-1 in Subjects with Coronary Artery Disease
Narayani Jayakumari et al.
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Paraoxonase (PON1) and the risk for coronary heart disease and myocardial infarction in a general population of Dutch women
Thomas M. van Himbergen et al.
ATHEROSCLEROSIS (2008)
The human paraoxonase-1 phenotype modifies the effect of statins on paraoxonase activity and lipid parameters
Hossein Z. Mirdamadi et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
The relationships between PON1 activity as well as oxLDL levels and coronary artery diabetes mellitus or impaired in CHD patients with fasting glucose
Chengzhi Lu et al.
CORONARY ARTERY DISEASE (2008)
Hyperhomocysteinemia, paraoxonase activity and risk of coronary artery disease
Mohsen Kerkeni et al.
CLINICAL BIOCHEMISTRY (2006)
Allelic variants of the human scavenger receptor class B type 1 and paraoxonase 1 on coronary heart disease -: Genotype-phenotype correlations
F Rodríguez-Esparragón et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Oxidative stress and its association with coronary artery disease and different atherogenic risk factors
C Vassalle et al.
JOURNAL OF INTERNAL MEDICINE (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: Studies in PON1-knockout mice
O Rozenberg et al.
FREE RADICAL BIOLOGY AND MEDICINE (2003)
Extensive association analysis between polymorphisms of PON gene cluster with coronary heart disease in Chinese Han population
XL Wang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Coronary artery disease is associated with the ratio of apolipoprotein A-I/B and serum concentration of apolipoprotein B, but not with paraoxonase enzyme activity in Iranian subjects
M Rahmani et al.
ATHEROSCLEROSIS (2002)
Paraoxonase Gln-Arg(192) and Leu-Met(55) gene polymorphisms and enzyme activity in a population with a low rate of coronary heart disease
N Ferré et al.
CLINICAL BIOCHEMISTRY (2002)
Paraoxonase status in coronary heart disease - Are activity and concentration more important than genotype?
B Mackness et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Promoter polymorphism T(-107)C of the paraoxonase PON1 gene is a risk factor for coronary heart disease in type 2 diabetic patients
RW James et al.
DIABETES (2000)
Share Paper
